These data indicate that CSF-1R inhibitors can effectively control lung cancer progression without affecting TAM density in whole tumours, but can profoundly alter TAM spatial distribution within lesions and/or their polar phenotype41, 42, 43, 44. Here, CSF1R is linked to lung carcinoma.